AarogyaAI Innovations, a healthtech firm, has raised $700,000 (about Rs 5.2 crore) in a seed fundraising round led by Info Edge (India)-backed Redstart Labs and Avaana Capital (Seed Program). Entrepreneur First (EF) and First In Ventures, both existing investors, also participated in the round.
The startup, founded in 2019 by scientists Praapti Jayaswal and Avlokita Tiwari, has developed a SaaS (software-as-a-service) platform that allows patients to upload the DNA sequence from the bacteria infecting them, which is then analysed using a machine learning (ML) algorithm and AI to generate a report that shows the patient’s comprehensive drug susceptibility status.
According to Praapti Jayaswal, Co-founder and Chief Executive Officer (CEO), the funds would be utilised primarily for R&D, team expansion, validation, and pilot deployments.